21054 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors from animals; from humans
RAAV-BASED COMPOSITIONS AND METHODS
#302PROTECTION AND SEALING OF THE OCULAR SURFACE BARRIER BY CLUSTERIN
#303COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN FUSION MOLECULES
#304POTENTIATION OF ANTICANCER AGENTS
#305USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN
#306Formulation Comprising A Stabilized Complex Of Corticotropin Releasing Hormone And Alpha-2 Macroglobulin
#307METHOD OF TREATING RESPIRATORY DISORDERS
#308Compositions of alpha-1 antitrypsin fusion molecules
#309Methods for preventing post-operative complications of cardiopulmonary surgery
#310Methods of treatment using alpha-1-antitrypsin compositions
#311C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
#312CYSTATIN C AND CYSTATIN 9 TO TREAT INFLAMMATION CAUSED BY BACTERIA
#313Compositions and methods for treating neonatal biliary atresia
#314COMPOSITIONS AND METHODS RELATED TO GRAFT VERSUS HOST DISEASE AND TREATMENTS THEREOF
#315COMPOSITION OF NOVEL POWDER FORMULATIONS OF TRANEXAMIC ACID
#316C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
#317C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
#318METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR
#319THERAPEUTIC COMPOSITION CONTAINING ANTITHROMBIN GAMMA
#320DIABETES TREATMENT
#321LDL QUANTITATION AND METHODS OF USE
#322C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
#323Technology for preparation of macromolecular microspheres
#324USE OF TRPC6 MRNA LEVELS IN PERIPHERAL BLOOD CELLS FOR EARLY DETECTION/DIAGNOSIS OF SENILE DEMENTIA
#325Pigment epithelium derived factor (PEDF) for the treatment of uterine fibroids
#326Protease triggered release of molecules from hydrogels
#327CHEMOREPULSION OF CELLS
#328COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN OR DERIVATIVES THEREOF
#329GENETICALLY MODIFIED MESENCHYMAL STEM CELLS EXPRESSING ALPHA-1 ANTITRYPSIN (AAT)
#330RAAV-BASED COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTI-TRYPSIN DEFICIENCIES
#331Method of treating overweight or obesity comprising administering a pleurotus ostreatus mushroom extract or a composition comprising a pleurotus ostretus mushroom extract
#332Therapeutic variant alpha-2-macroglobulin compositions
#333COMPOSITIONS AND METHODS FOR TREATING POST-OPERATIVE COMPLICATIONS OF CARDIOPULMONARY SURGERY
#334Envenomation therapies and related pharmaceutical compositions, systems and kits
#335Drug therapy to inhibit chemotherapy-induced adverse effects and related pharmaceutical compositions, diagnostics, screening techniques and kits
#336NOVEL FERMENTED MILK PRODUCT AND METHOD FOR PRODUCING THE SAME
#337NOVEL CHEESE AND METHOD FOR PRODUCING THE SAME
#338METHOD OF ENHANCING VIRAL-MEDIATED GENE DELIVERY
#339NOVEL POWDERED MILK PRODUCT AND METHOD FOR PRODUCING THE SAME
#340Alpha-1 anti-trypsin for treating liver diseases
#341WOUND FLUID ELEVATED PROTEASE ENZYME INHIBITION THROUGH CAMELID BLOOD PRODUCTS
#342Protease triggered release of molecules from hydrogels
#343Treatment of disease using inter-alpha inhibitor proteins
#344METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITIS
#345COMPOSITIONS OF, AND METHODS FOR, ALPHA-1 ANTITRYPSIN Fc FUSION MOLECULES
#346METHODS OF MODULATING BONE REMODELING
#347Lipid nanoparticle compositions and methods for MRNA delivery
#348Methods for treatment of and prophylaxis against inflammatory disorders
#349Administration of serine protease inhibitors to the stomach
#350C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY
#351Pigment epithelium-derived factor (PEDF) and peptide derivatives thereof for use in osteoblast differentiation and bone growth
#352Compositions and Methods for Modulating Cardiac Conditions
#353Combined therapy of alpha-1-antitrypsin and temporal T-cell depletion for preventing graft rejection
#354Methods of treating or preventing periodontitis and diseases associated with periodontitis
#355Methods for preventing or treating optic neuritis
#356PEPTIDE AND A USE THEREOF
#357Preparation and composition of inter-alpha inhibitor proteins from blood
#358Use of metalloproteinase inhibitors against bacterial infections
#359Methods for preventing and/or treating nasal polyps and rhinosinusitis
#360PAR-1 based therapeutic conjugates and uses thereof
#361COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE
#362LOCAL ADMINISTRATION OF DRUGS FOR THE TREATMENT OF ASTHMA
#363Methods of treatment using alpha-1-antitrypsin compositions
#364Compositions Comprising Variegin
#365Compositions and methods for preparing a subject for organ or non-organ implantation
#366Use of the binding domain of a subunit of a multi-subunit structure for targeted delivery of pharmaceutically active entities to the multi-subunit structure
#367COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN BONE MARROW TRANSPLANTATION AND TREATMENT OF GRAFT VERSUS HOST DISEASE
#368High-selectivity contact activation inhibitor based on infestin-4
#369Methods for treating hidradenitis suppurativa
#370Prevention and reduction of blood loss
#371TREATMENT OF HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR
#372METHOD FOR INCREASING THE BIOAVAILABILITY OF INHALED COMPOUNDS
#373rAAV-based compositions and methods
#374COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX
#375SERPIN DRUGS FOR TREATMENT OF VIRAL INFECTION AND METHOD OF USE THEREOF
#376HDL comprising a therapeutic agent and use in therapy
#377HYDROXYALKYL STARCH DERIVATIVES AS REACTANTS FOR COUPLING TO THIOL GROUPS
#378Cellular Factor-Containing Solution Compositions for the Treatment of Rhinovirus Infection and Symptoms
#379Methods of treating joint diseases, disorders, and conditions with tissue inhibitors of matrix metalloproteinases
#380Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
#381Protein Formulations Containing Amino Acids
#382TISSUE INHIBITOR OF METALLOPROTEINASES (Timp) LINKED TO GLYCOSYLPHOSPHATIDYLINOSITOL (Gpi) - ANCHORS FOR TREATMENT OF CANCER AND SKIN LESIONS
#383Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer
#384Modified anti-inflammatory proteins and method of use
#385Compositions and methods for treating granulomatosis with polyangiitis
#386Methods for treating ophthalmic disorders, diseases and injuries
#387APROTININ-DERIVED POLYPEPTIDE-ANTIBODY CONJUGATES
#388Methods For Treating Tissue Fibrosis
#389Methods and compositions for detecting coagulation inhibitors
#390INFANT NUTRITION WITH PROTEASE INHIBITOR
#391COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C-1 INHIBITOR
#392TREATMENT OF CONDITIONS RELATED TO SHOCK
#393Maspin, Maspin Derivatives, and Maspin Mimetics for Reducing ROS, Inflammation, and Skin Aging
#394FORMULATIONS OF LIQUID STABLE ANTITHROMBIN
#395COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN OR DERIVATIVES THEREOF
#396Methods for accelerating the healing of connective tissue injuries and disorders
#397Compositions And Methods For Heparan Sulfate As A Biomarker For Transplant Rejection
#398METHODS FOR ANALYZING ELASTIC FIBER INJURY MARKERS AND DIAGNOSIS OF DISEASES ASSOCIATED WITH ELASTIC FIBER INJURY
#399COMPOSITIONS CONTAINING HC-HA COMPLEX AND METHODS OF USE THEREOF
#400Compositions and methods for preventing injury during or resulting from cardiac surgery
#401COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES OF INFECTIOUS AND NON-INFECTIOUS ORIGIN
#402Methods and compositions for oral administration
#403DIABETES TREATMENT
#404Method of deriving mature hepatocytes from human embryonic stem cells
#405C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
#406NOVEL POWDERED MILK PRODUCT AND METHOD FOR PRODUCING THE SAME
#407Treatment and prevention of remote ischemia-reperfusion injury
#408Therapeutic agent for amniotic fluid embolism
#409Use of TRPC6 mRNA levels in peripheral blood cells for early detection/diagnosis of senile dementia
#410Methods and compositions for the disruption of biofilms
#411METHOD AND COMPOSITION FOR CONFERRING NEUROPROTECTION
#412Methods and Pharmaceutical Compositions for Prevention of Aging-Related Lesions
#413GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS
#414METHODS AND COMPOSITIONS FOR TREATING NAFLD, HEPATIC STEATOSIS, AND SEQUELAE THEREOF
#415Methods of treatment using alpha-1-antitrypsin compositions
#416Potentiation of anticancer agents
#417METHODS FOR DIAGNOSING AND/OR TREATING STERILITY
#418NOVEL PROTEIN MATERIAL
#419Use of PEDF-derived polypeptides for treating osteoarthritis
#420Treatment of disease using inter-alpha inhibitor proteins
#421Methods for treating cardiac conditions
#422Methods and compositions for the treatment of ischemic injury to tissue using therapeutic hypothermia
#423Use of PEDF-derived polypeptides for preventing and/or ameliorating skin aging
#424CELL SYSTEMS AND METHODS FOR DELIVERING DISEASE-SPECIFIC THERAPIES
#425NOVEL CHEESE AND METHOD FOR PRODUCING THE SAME
#426NOVEL FERMENTED MILK PRODUCT AND METHOD FOR PRODUCING THE SAME
#427METHODS FOR REDUCING CELLULAR SENESCENCE MEDIATED BY DNA DAMAGING AGENTS
#428Systems, compositions, and methods for transplantation
#429Use of serine protease inhibitors in the treatment of neutropenia
#430Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes
#431Medicament for therapeutic treatment and/or improvement of sepsis
#432Methods of treating antibody-mediated rejection in organ transplant patients with C1-esterase inhibitor
#433Oral Leptin Formulations and Uses Thereof
#434Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders
#435Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes
#436METHODS OF INHIBITING THE ALTERNATIVE PATHWAY OF COMPLEMENT IMMUNE SYSTEM ACTIVATION AND COMPOSITIONS USED THEREIN
#437Anti-Inflammatory Composition for Modulating the Cell Response of Neutrophils and Eosinophils
#438Method for treating inflammation with an -TMP-2 protein
#439Methods to reduce scarring
#440Methods for treating cardiac conditions
#441Methods and compositions for treating diabetes
#442Alpha1 proteinase inhibitor peptides methods and use
#443Alpha 1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
#444COMBINED THERAPY OF ALPHA-1-ANTITRYPSIN AND TEMPORAL T-CELL DEPLETION FOR PREVENTING GRAFT REJECTION
#445POLYSACCHARIDE-PROTEIN CONJUGATES REVERSIBLY COUPLED VIA IMINE BONDS
#446Factor XII inhibitors for the treatment of neurological inflammatory disorders
#447Use of C1-inhibitor for the treatment of secondary edema of the central nervous system
#448Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules
#449Identification and molecular characterisation of proteins, expressed in the salivary glands
#450Prevention and reduction of blood loss
#451Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
#452Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis
#453Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
#454POLYMERIC CONJUGATES OF C-1 INHIBITORS
#455Therapeutic agent for preterm delivery or abortion using plasminogen activator inhibitor-1
#456Ethanol dependence of alpha1 antitrypsin C-terminal Lys truncation by basic carboxypeptidases
#457Inhibitors against endosomal/lysosomal enzymes
#458Immunocompatible chorionic membrane products
#459Compositions and methods for preparing a subject for organ or non-organ implantation
#460Medicament for therapeutic treatment and/or improvement of sepsis
#461Pulmonary delivery of mRNA
#462MRNA therapy for Fabry disease
#463Immunocompatible amniotic membrane products
#464Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
#465DUAL REACTIVITY POTENT KUNITZ INHIBITOR OF FIBRINOLYSIS
#466FORMULATIONS THAT STABILIZE PROTEINS
#467Compositions and methods related to graft versus host disease and treatments thereof
#468Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#469Combination therapy using immunoglobulin and C1-Inhibitor
#470RECOMBINANT HUMAN ALPHA-1-ANTITRYPSIN FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#471USE OF ANTITHROMBIN IN THE TREATMENT OF PRE-ECLAMPSIA
#472Use of antithrombin in extracorporeal membrane oxygenation
#473Protease triggered release of molecules from hydrogels
#474COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE
#475Manufacturing and purification processes of Complex protein found in Fraction IV to make a separated Apo, Transferrin, and Alpha 1 Antitrypsin (A1AT) or a combined Transferrin/Apo/Human Albumin/A1AT and all new found proteins
#476Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin, and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin/Apo/Human Albumin/A1AT and all new found proteins
#477Methods of manufacture of immunocompatible chorionic membrane products
#478Methods of manufacture of immunocompatible amniotic membrane products
#479Protein formulations containing amino acids
#480COMPOSITIONS AND METHODS RELATED TO GRAFT VERSUS HOST DISEASE AND TREATMENTS THEREOF
#481Methods of manufacture of therapeutic products comprising vitalized placental dispersions
#482Methods of modulating bone remodeling
#483Method for ameliorating radiation exposure effects with alpha-1 antitrypsin
#484Methods for treating ophthalmic disorders, diseases and injuries
#485Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
#486Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
#487Drug therapy to inhibit chemotherapy-induced adverse effects and related pharmaceutical compositions, diagnostics, screening techniques and kits
#488Therapeutic products comprising vitalized placental dispersions
#489COMPOSITIONS AND METHODS FOR TREATING BONE FORMATION DISORDERS
#490TREATMENT OF MENSTRUAL PAIN AND EXCESSIVE MENSTRUAL BLOOD LOSS BY INTRAVAGINAL ADMINISTRATION OF A LOW DOSE OF ANTIFIBRINOLYTIC OR HEMOSTATIC AGENT IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUG
#491Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof
#492Administration of serine protease inhibitors to the stomach
#493Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis
#494Cellular-factor containing solution compositions
#495NOVEL USES OF ELAFIN
#496Biomarker and uses thereof in diagnosis, treatment of autism
#497Use of C1 inhibitor for the prevention of ischemia-reperfusion injury
#498Medicament for therapeutic treatment and/or improvement of sepsis
#499SKIN COLLAGEN PRODUCTION-PROMOTING AGENT
#500Method of deriving mature hepatocytes from human embryonic stem cells
#501Methods and compositions for oral administration of exenatide
#502Compositions and methods for modulating cardiac conditions
#503Thrombin inhibitor
#504Methods for promoting hair growth
#505USE OF SPINK6 GENE AND ITS ENCODED PROTEIN FOR THE PREPARATION OF AN ANTI-TUMOR DRUG
#506Identification and molecular characterisation of proteins, expressed in the salivary glands
#507Protease Inhibitors and Preventives or Remedies for Disease
#508Wound healing device comprising a cloth embedded with a wound healing composition
#509COMPOSITIONS AND METHODS FOR PRODUCING ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS WITH SYNTHETIC NANOCARRIERS
#510INDUCED TOLEROGENIC DENDRITIC CELLS FOR INDUCING REGULATORY B CELLS
#511COMPOSITIONS AND METHODS RELATED TO INDUCED TOLEROGENIC DENDRITIC CELLS EXTERNALLY LOADED WITH MHC CLASS I-RESTRICTED EPITOPES
#512ALLERGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS FOR ALLERGY THERAPY
#513ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE ANTIBODY RESPONSES
#514ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES
#515INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE SYSTEMIC INFLAMMATORY CYTOKINES
#516INDUCED TOLEROGENIC DENDRITIC CELLS FOR GENERATING CD8+ REGULATORY T CELLS
#517DENDRITIC CELL SUBSETS FOR GENERATING INDUCED TOLEROGENIC DENDRITIC CELLS AND RELATED COMPOSITIONS AND METHODS
#518TRANSPLANTABLE GRAFT-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE
#519THERAPEUTIC PROTEIN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE
#520Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes
#521Cytokine containing compositions
#522METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITIS
#523LDL QUANTITATION AND METHOD OF USE
#524Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
#525Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
#526Cytokine containing compositions
#527Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies
#528Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation
#529METHODS AND COMPOSITIONS TO TREAT HEMORRHAGIC CONDITIONS OF THE BRAIN
#530USE OF APROTININ FOR TREATING PARASITIC INFECTIONS AND PROGNOSING BOVINE TRYPANOTOLERANCE
#531Disease treatment via antimicrobial peptides or their inhibitors
#532INFANT NUTRITION WITH PROTEASE INHIBITOR
#533COMPOSITIONS AND METHODS FOR PREVENTION OF PHOTOAGING
#534Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NK cell activity
#535Cellular factor-containing solution compositions
#536Compositions And Methods For Cell Based Retinal Therapies
#537POLYPEPTIDES THAT BIND TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
#538Methods for treating radiation burns
#539COMPOSITIONS, METHODS AND USES FOR TREATMENT OF TYPE 1 DIABETES
#540Kits for treating wounds
#541Glycopegylation methods and proteins/peptides produced by the methods
#542PULMONARY DELIVERY OF ALPHA-1 PROTEINASE INHIBITOR
#543Stem Cell Conditioned Medium Compositions
#544POLYPEPTIDES AND USES THEREOF
#545Treatment and prevention of pulmonary conditions
#546USES OF CYSTATIN
#547Heparin cofactor II fragments with anti-inflammatory and anti-coagulant activity
#548Methods for accelerating the healing of connective tissue injuries and disorders
#549Method of reducing side effects associated with administration of tissue plasminogen activator (tPA)
#550Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
#551Alpha-1-antitrypsin compositions and methods of use
#552Methods related to surgery
#553PREVENTION OF THROMBUS FORMATION AND/OR STABILIZATION
#554Technology for preparation of macromolecular microspheres
#555Methods for treating wounds
#556NANOPARTICULATE-BASED CONTRACEPTIVE/ANTI-HIV COMPOSITION AND METHODS
#557COMPOSITIONS AND METHODS TO MODULATE PROGRESSION AND ONSET OF INFLAMMATORY BOWEL DISEASE
#558METHODS AND MATERIALS FOR ASSESSING PROSTATE CANCER RECURRENCE AND REDUCING MESOTRYPSIN ACTIVITY
#559Use of C1 inhibitor for the prevention of ischemia-reperfusion injury
#560Mutated antithrombins, a process for preparing the same and their use as drugs
#561Compositions containing HC-HA complex and methods of use thereof
#562Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#563Genetically modified TFPI and method of treating coagulation using the same
#564Method of treating thrombocytopenia
#565METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL
#566Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
#567METHODS AND COMPOSITIONS FOR ISLET CELL PRESERVATION
#568METHODS AND COMPOSITIONS FOR TREATING DIABETES
#569Kallikrein-inhibitor therapies
#570Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer
#571Use Of Serine Protease Inhibitors In The Treatment Of Neutropenia
#572Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury
#573XIAP THERAPY
#574Wound healing device
#575Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
#576EXOGENOUS MATRIX-SUPPORTED TOPICAL APPLICATION OF STEM CELLS TO ORGAN SURFACE
#577IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS
#578Glue composition for lung volume reduction
#579ANTINECROTIC ACTIVITY OF ALPHA 1-ANTITRYPSIN
#580Micronized device for the delivery of biologically active molecules and methods of use thereof
#581ANTI-INFECTIVE COMPOUNDS AND USES THEREOF
#582IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
#583METHODS OF MANUFACTURE OF THERAPEUTIC PRODUCTS COMPRISING VITALIZED PLACENTAL DISPERSIONS
#584THERAPEUTIC PRODUCTS COMPRISING VITALIZED PLACENTAL DISPERSIONS
#585METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
#586METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS
#587Encapsulated functional fine particle composition capable of spraying and preparation method thereof
#588Preparation and composition of inter-alpha proteins from blood
#589Methods for treating ophthalmic disorders, diseases and injuries
#590Treatment of Solid Tumors with Tissue Inhibitors of Metalloproteinases (TIMPS)
#591Ultra-high yield of alpha-1-anti-trypsin
#592Methods and compositions to treat hemorrhagic conditions of the brain
#593Methods and compositions for oral administration of insulin
#594USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES
#595METHOD OF REGULATING THE HEAT SHOCK RESPONSE
#596ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#597COMPOSITIONS, METHODS AND USES FOR TREATING DIABETES
#598Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors for treatment of cancer and skin lesions
#599PROTEASE INHIBITORY PEPTIDES
#600Polysaccharide-protein conjugates reversibly coupled via imine bonds